Successful rechallenge with cetuximab after an infusion related reaction to panitumumab in a patient with locally advanced rectal cancer

Incidence of infusion related reaction (IR) is more common with cetuximab (Cmab) than with panitumumab (Pmab). Although little is known about rechallenge IR with monoclonal antibodies, we experienced a successful rechallenge to Cmab after IR to Pmab. A 67-year-old female patient was scheduled for ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokokawa, Hideyuki, Kono, Teppei, Shidei, Hiroaki, Oyama, Kunihiro, Ito, Yoshitomo, Imaizumi, Rie, Miyano, Yutaka, Shiozawa, Shunichi, Yoshimatsu, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797389/
https://www.ncbi.nlm.nih.gov/pubmed/33489709
http://dx.doi.org/10.1007/s13691-020-00455-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797389/
https://www.ncbi.nlm.nih.gov/pubmed/33489709
http://dx.doi.org/10.1007/s13691-020-00455-x

Ejemplares similares